The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ProKidney Corp shares valued at $276,366 were purchased by Control Empresarial de Capital on Apr 22 ’25. At $0.71 per share, Control Empresarial de Capital acquired 387,393 shares. The insider’s holdings grew to 73,842,723 shares worth approximately $66.46 million following the completion of this transaction.
Also, Control Empresarial de Capital purchased 25,000 shares, netting a total of over 18,690 in proceeds. Following the buying of shares at $0.75 each, the insider now holds 73,455,330 shares.
Before that, Control Empresarial de Capital had added 100,000 shares to its account. In a trade valued at $74,820, the Add’l Rep. Persons-see Ex.99-1 bought ProKidney Corp shares for $0.75 each. Upon closing the transaction, the insider’s holdings increased to 100,000 shares, worth approximately $66.09 million.
As published in their initiating research note from JP Morgan on September 30, 2024, ProKidney Corp [PROK] has been a Neutral. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in early September. Earlier on January 02, 2024, BofA Securities downgraded its rating. Their new recommendation was “a Neutral” for PROK stock which previously was a “a Buy”.
Analyzing PROK Stock Performance
On last trading session,, ProKidney Corp [NASDAQ: PROK] plunged -4.16% to $0.90. The stock’s lowest price that day was $0.8942, but it reached a high of $0.9827 in the same session. During the last five days, there has been a surge of approximately 13.85%. Over the course of the year, ProKidney Corp shares have dropped approximately -46.98%.
Support And Resistance Levels for ProKidney Corp (PROK)
RSI (Relative Strength Index) is 55.72 on the 14-day chart, showing neutral technical sentiment.
Is ProKidney Corp subject to short interest?
Stocks of ProKidney Corp saw a sharp rise in short interest on 2025-05-30 jumping by 0.88 million shares to 16.52 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 15.64 million shares. A jump of 5.35% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 26.84 of the overall float, the days-to-cover ratio (short ratio) jumped to 26.84.
Which companies own the most shares of ProKidney Corp (PROK)?
In terms of ProKidney Corp share price expectations, FactSet research, analysts set an average price target of 5 in the next 12 months, up nearly 437.63% from the previous closing price of $0.93. Analysts anticipate ProKidney Corp stock to reach 6 by 2025, with the lowest price target being 3. In spite of this, 6 analysts ranked ProKidney Corp stock as Buy at the end of 2025. On July 25, 2023, BTIG Research assigned a price target of “a Buy” to the stock and initiated coverage with a $16.
